• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Curis (CRIS)

Common Shares
Sell: $1.18|Buy: $1.29|Change: 0.13 (-10.08%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Address

4 Maguire Road
Lexington
MA
USA
02421

Telephone

+1 617 503-6500

Website

https://www.curis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Curis Inc Third Quarter Earnings Conference Call for 20262026-11-06T16:30:00
Curis Inc Third Quarter Earnings Results for 20262026-11-06T16:00:00
Curis Inc Second Quarter Earnings Conference Call for 20262026-08-05T08:30:00
Curis Inc Second Quarter Earnings Results for 20262026-08-05T08:00:00
Curis Inc Annual General Meeting for 20252026-05-20T10:00:00
Curis Inc First Quarter Earnings Conference Call for 20262026-05-06T08:30:00
Curis Inc First Quarter Earnings Results for 20262026-05-06T08:00:00
Curis Inc Fourth Quarter Earnings Conference Call for 20252026-03-31T08:30:00
Curis Inc Fourth Quarter Earnings Results for 20252026-03-31T08:00:00
Curis Inc Annual Report for 20252026-03-31T00:00:00

Previous key dates

NameKey Date
Curis Inc Third Quarter Earnings Conference Call for 20252025-11-06T16:30:00
Curis Inc Third Quarter Earnings Results for 20252025-11-06T16:00:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-10T10:00:00
The Cantor Global Healthcare Conference2025-09-05T09:45:00
Curis Inc Second Quarter Earnings Conference Call for 20252025-08-05T08:30:00
Curis Inc Second Quarter Earnings Results for 20252025-08-05T08:00:00
Curis Inc Annual General Meeting for 20242025-05-20T10:00:00
Curis Inc First Quarter Earnings Conference Call for 20252025-05-06T08:30:00
Curis Inc First Quarter Earnings Results for 20252025-05-06T08:00:00
Jones Healthcare and Technology Innovation Conference2025-04-09T16:30:00
Curis Inc Fourth Quarter Earnings Conference Call for 20242025-03-31T08:30:00
Curis Inc Fourth Quarter Earnings Results for 20242025-03-31T08:00:00
Curis Inc Annual Report for 20242025-03-31T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.